LexDanaLexDanabeta
Inventor

DHARMINDER CHAUHAN

Inventor
US

Overview

3→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
PatentTitleYear
11,802,132Small molecules for inducing selective protein degradation and uses thereof202311,702,402Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereof202311,465,983USP7 inhibitors for treating multiple myeloma2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history
2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DANA FARBER CANCER INST INC32022–2023
Locations
LocationPatentsSpan
US32022–2023